Analyzing Novozymes A/S (OTCMKTS:NVZMY) & 5E Advanced Materials (NASDAQ:FEAM)

5E Advanced Materials (NASDAQ:FEAM) and Novozymes A/S (OTCMKTS:NVZMY) are both basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Risk and Volatility

5E Advanced Materials has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, Novozymes A/S has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.

Earnings & Valuation

This table compares 5E Advanced Materials and Novozymes A/S”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
5E Advanced Materials	N/A	N/A	-$31.56 million	($7.03)	-0.24
Novozymes A/S	$4.15 billion	N/A	$330.91 million	$1.69	35.62

Novozymes A/S has higher revenue and earnings than 5E Advanced Materials. 5E Advanced Materials is trading at a lower price-to-earnings ratio than Novozymes A/S, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

0.0% of Novozymes A/S shares are owned by institutional investors. 0.2% of 5E Advanced Materials shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares 5E Advanced Materials and Novozymes A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
5E Advanced Materials	N/A	-71.87%	-63.88%
Novozymes A/S	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings for 5E Advanced Materials and Novozymes A/S, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
5E Advanced Materials	1	1	2	0	2.25
Novozymes A/S	0	1	0	0	2.00

5E Advanced Materials presently has a consensus target price of $8.13, suggesting a potential upside of 372.38%. Given 5E Advanced Materials’ stronger consensus rating and higher possible upside, equities analysts plainly believe 5E Advanced Materials is more favorable than Novozymes A/S.

Summary

Novozymes A/S beats 5E Advanced Materials on 7 of the 12 factors compared between the two stocks.

About 5E Advanced Materials

5E Advanced Materials, Inc. engages in the exploration and development of mineral properties in Australia and the United States. The company primarily explores for borates and lithium deposits. It holds 100% interest in the Fort Cady project located in the Mojave Desert region in eastern San Bernardino County, California. The company was formerly known as American Pacific Borates Limited. The company was incorporated in 2016 and is based in Hesperia, California.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.